Chemical Structure : SBP-1750
Catalog No.: PC-25796Not For Human Use, Lab Use Only.
SBP-1750 is a novel potent ULK inhibitor with IC50 of 8 nM and 50 nM for ULK1 and ULK2 respectively in ADP-Glo kinase assays, induces effective ATG13 degradation in A549 cells with EC50 of 114 nM in In-Cell Western blots (ICWBs) assays.
Bulk size, bulk discount!
Welcome credit card payment!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
SBP-1750 is a novel potent ULK inhibitor with IC50 of 8 nM and 50 nM for ULK1 and ULK2 respectively in ADP-Glo kinase assays, induces effective ATG13 degradation in A549 cells with EC50 of 114 nM in In-Cell Western blots (ICWBs) assays.
SBP-1750 exhibits cellular activity in the ULK1 NanoBRET assay with IC50 of 4.1 nM.
SBP-1750 may induce ATG13 degradation through a proteasomal pathway, MG132 significantly alters the level of ATG13 degradation.
SBP-1750 impaired ATG, and induced KRAS mutant cancer cell death.
SBP-1750 significantly reduced tumor growth in KRAS-mutant orthotopic syngeneic pancreatic cancer model.
| M.Wt | 443.89 | |
| Formula | C21H22ClN5O4 | |
| Appearance | Solid | |
| Storage |
|
|
| Solubility |
10 mM in DMSO |
|
1. Hagan PM, et al. bioRxiv [Preprint]. 2025 Oct 15:2025.10.14.682402.

Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright